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Abstract
The prediction of patient mortality in the healthcare system provides a metric by which
hospitals can better manage patient care and assess the needs of each individual patient. As such,
the development of better predictive methods is vital for improving patient outcomes and overall
quality of care. Heart rate variability (HRV) is a measure of the heart’s complex beating patterns,
giving medical professionals additional insight into patient health. Previous research has
demonstrated the potential use of heart rate variability as a metric for patient mortality prediction
for various conditions, however more work is necessary to validate HRV as a metric for a
broader and more diverse set of patients. This study uses data from 2664 patients within the
MIMIC-III clinical database matched with patient electrocardiogram (ECG) data to link HRV
data with later patient mortality, examining the efficacy of HRV as a biomarker for predicting
patient mortality and investigating possible avenues for future integration of HRV into patient
mortality predictive algorithms.

Introduction
In a clinical setting, methods for predicting patient outcomes, and particularly patient
mortality, are often used to enhance the decision-making of health-care professionals. These
methods score patients based on a variety of physiological data points, attempting to provide a
holistic picture of a patient’s health status. This knowledge can then influence which treatments
are considered and the level of urgency with which a particular patient is treated, and improve
the quality of care provided. The development of better models for predicting patient mortality
provides a promising path towards improving patient outcomes [1-3].
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Heart rate variability (HRV) is a term describing the natural variation in the timing
between subsequent heart beats. This gap is designated as an inter-beat interval or RR interval,
named in relation to the QRS complex of a heartbeat as observed on an ECG, where the ‘R’
denotes the peak of electrical activity. When applied specifically to subsequent normal beats,
filtering out beats that are classified as ectopic or otherwise abnormal, this is also called an NN
interval [4]. Alongside time domain measurements that are derived from this interval, frequency
domain measurements examine various frequency bands derived from the electrical signal of the
heart. High variability is often associated with good cardiac health; a healthy heart follows
complex behavior and more easily adapts to changes in conditions, with greater variability
allowing for a better response. However, high HRV can also be a result of various pathologies,
the most common of which being cardiac arrhythmias such as atrial fibrillation. As such, HRV
analysis can provide insights on cardiovascular health. HRV measurements are also highly
sensitive to context, and age, sex, and length of measurement must be considered for proper
interpretation [5].
HRV has been well established as a component of heart health, particularly useful for
patients suffering from cardiac conditions and those at risk for such diseases. A comprehensive
systematic review of clinical studies examining HRV statistics in relation to patients recovering
from an ST-elevation myocardial infarction, colloquially known as a heart attack, found a strong
link between low HRV and later health concerns. Various studies examined in the review found
a statistically significant relationship between measures such as SDNN, RMSSD, SDANN, mean
RR interval, and frequency-domain measures, and later major clinical events, recurrent
myocardial infarction, and later mortality, both from general causes and cardiac-related events
[6]. Despite their value in assessing cardiovascular health, no commonplace methods of

5

predicting patient mortality integrate HRV statistics. However, evidence shows that HRV is a
potential predictor of patient mortality in cases of COVID-19, traumatic brain injury, and sepsis
[7-9]. Further validation may open the door for use of HRV measurements for both targeted and
general use patient outcome prediction models.
HRV statistics, as quantitative assessments of heart health, are well-suited to machine
learning approaches, and can be easily integrated into existing models. Many patient mortality
models function by assigning weights to several numerical medical measurements; one such
application, the ALaRMS (Acute Laboratory Risk of Mortality Score) model, has found success
in using a logistic regression approach to fit a wide variety of standard laboratory measurements
into a prediction model [3]. Machine learning approaches are capable of recognizing and
capitalizing on patterns within patient data that are not readily apparent to human observers.
Such methods can also provide valuable information on the relevance and predictive capacity of
various elements within the data, highlighting the most important factors in predicting outcomes.
Machine learning methods have been shown to outperform other methods of evaluating patient
mortality in sepsis patients, and may be applicable in a more general population [10]. However,
machine learning methods are also highly reliant on data quantity and quality, and careful
consideration should be given to data selection. Proper methodology and implementation of
machine learning methods cannot compensate for poor quality data or data lacking in significant
predictors. Alongside small sample size, these limiting factors can also lead to results that do not
translate well to other similar datasets [11].
Finally, the growing body of publicly available data in the healthcare field presents an
unparalleled opportunity for community-driven scientific progress. The sharing of data when
possible, with regulations in place for deidentification of sensitive health data, allows data to be
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used for research in areas far beyond the initial investigation’s direction and scope. The MIMICIII database, along with its predecessors and newer addition MIMIC-IV, is one such resource,
allowing credentialed access to deidentified electronic health records for over 40,000 patients of
the Beth Israel Deaconess Medical Center critical care unit. The dataset supports research in
multiple areas, but of specific note is the robust collection of ECG records matched to patients’
health and demographic information, which provides a significant amount of data for examining
HRV in relation to patient mortality in diverse populations [12-14].
This research aims to establish the efficacy of HRV statistic-based machine learning
algorithms in predicting patient mortality in a diverse critical care environment, and illuminate
future challenges and considerations in implementing such statistics into subsequent prediction
models.

Related Work
Several studies have investigated the potential of HRV statistics in predicting patient
outcomes for various conditions and situations. One such study examined the viability of the
standard deviation of NN intervals (SDNN) metric, derived from ultra-short ECG recordings of
10 seconds, in predicting COVID-19 patient mortality. The study, conducted with 271 patients
hospitalized with COVID-19, focused on 3-week survival and ICU readmission, and found that
higher SDNN values (>8 ms) were associated with better outcomes in both areas, particularly for
patients aged 70 year or older [7].
Another study, a systematic review on the relationship between HRV and patient
mortality following traumatic brain injury, looked at data collected from 542 patients. Using
frequency domain statistics, the study found that low frequency/high frequency (LF/HF) ratio,
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HF peak, and total power (TP) were each highly correlated with patient mortality [8]. A similar
study focused instead on patient mortality due to sepsis, and proposed several novel measures of
HRV that were strong predictors within their own dataset. In a cohort of 342 patients, a model
based on these measures outperformed patient mortality models such as APACHE and SOFA in
predicting patient mortality, based on the ROC curve [9].
Of studies relating to cardiovascular conditions, several characterized HRV statistics as
highly correlated with patient outcomes. One paper used many 24-hour features related to
SDNN, including SDNN itself, in a support vector machine-based approach to predict cardiac
death following myocardial infarction [15]. Another study similarly found that a decrease in 24hour SDNN and very low frequency band (VLF) values was associated with greater risk for
developing cardiac arrhythmias in patients following myocardial infarction [16]. A third study
followed 1757 patients diagnosed with coronary artery disease, and investigated SDNN In
particular as well. The study noted that a decrease in SDNN was correlated with a large increase
in risk of both sudden cardiac death and non-cardiac death [17].
Each of these studies further validates the notion that HRV is tied intimately to heart
health and overall health, and that HRV has predictive potential when it comes to patient
outcomes. Where each individual studies supports HRV as a predictor of outcomes for specific
patient populations and conditions, this study aims to validate these findings with a diverse
patient population, with varying medical conditions, for determining HRV efficacy in a general
patient mortality prediction model.
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Methods
Data Collection and Initial Processing
Electronic health record data and electrocardiogram data was collected from the MIMICIII clinical database and MIMIC-III waveform database matched subset, respectively. For
clinical data access, the CITI Data or Specimens Only Research course, as provided by the
Massachusetts Institute of Technology, was completed and submitted to Physionet.org for
review. The data use agreement for MIMIC-III was signed to indicate my agreement to data
security and adherence to protect health data privacy, and my account and personal details
verified to confirm my identity as a student researcher.
Data was downloaded and initially processed using the Physionet wfdb and pandas
python packages, creating a directory of all patient ECG files containing more than ten minutes
of data for each patient. Due to a combination of time constraints and processing constraints, this
was later amended to a single file per hospital stay per patient, with the five to ten minute
window specifically processed for HRV statistics for consistency between patients. During this
initial processing, ECG data was converted to a text file containing RR interval data, which was
then used for HRV calculations. Deidentified patient information, including mortality within
ninety, thirty, seven, and one days of recording start, was organized with the relevant HRV data
and stored.
HRV Analysis Approach
Six measures were calculated relating to patient ECG data. Average heart rate, in beats
per minute (bpm), was calculated alongside average RR interval duration in milliseconds (ms).
The minimum and maximum RR interval value, in ms, were also stored. The standard deviation
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of NN intervals, SDNN, was calculated for this 5 minute duration, along with the percentage of
NN intervals that differ by more than 50 ms, the PNN50 value. Values for heart rate, SDNN, and
PNN50 values were used for statistical analysis of the data as a whole. Statistical significance
was calculated using a Mann-Whitney U rank test, using the scipy Python library.
To briefly examine how HRV trends change in the time approaching patient death, a
small number of patients with multiple distinct ECG sessions within a short timeframe of patient
death were found and their data collected. Patients were selected that had at least one recording
within 10 days of death, at least one recording between 10 and 20 days of death, and at least one
recording between 20 and 30 days of death. A full body of all ECG recordings exceeding 10
minutes was downloaded, and a series of 5 minute HRV statistics recorded for the length of each
sample. HRV statistics were generated individually for each ECG session. This data was then
used to plot the trajectory of patient heart rate, SDNN, and PNN50 in the 30 days prior to patient
death. For estimating recording date, all samples had their respective date assigned as the
waveform record date, as recorded in the master header files for each recording session.
Machine Learning Approach
A logistic regression model was created and trained on the data using the Python scikitlearn library. Heart rate, SDNN, and PNN50 were used to predict patient mortality within ninety
days, thirty days, seven days, and one day. Following training, the model was tested on
validation data and various metrics related to model accuracy were collected. A random test
subset of 75% was used for model training, while a complementary testing subset of 25% was
used for model validation, using the scikit-learn train_test_split() method.
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Results
Of 4,753 patients whose ECG data was downloaded, 2,664 had data that was compatible
with the wfdb peak detection algorithm without further processing. Signal noise within the raw
ECG data could interfere with peak detection, causing the peak detection to fail and no list of
RR-intervals to be generated. The statistical results derived from the remaining data are
displayed in Table 1 below.

Table 1
Heart rate and HRV statistics for 4259 independent hospital admissions, from 2664 patients
HR (bpm)*

SDNN (ms)*

PNN50 (%)*

Male (n = 2,366)

86.35 ± 22.02

34.00 ± 26.22

6.46 ± 10.50

Female (n = 1,893)

88.49 ± 22.40

35.21 ± 27.50

7.57 ± 10.92

Significance

p < 0.001

p = 0.009

p < 0.001

88.80 ± 22.80

34.65 ± 27.82

7.76 ± 22.79

(n = 3,456)

86.96 ± 22.06

34.51 ± 26.56

6.76 ± 10.62

Significance

p = 0.002

p = 0.766

p < 0.001

Gender and

Male, Deceased (n = 434)

87.96 ± 21.75

33.47 ± 26.71

7.61 ± 10.69

Mortality

Male, Alive (n = 1,932)

85.99 ± 22.07

34.12 ± 26.11

6.19 ± 10.44

Significance

p = 0.003

p = 0.669

p < 0.001

Gender

Mortality

Patient Deceased, 90 days
(n = 803)
Patient Alive, 90 days

11

Female, Deceased (n = 369)

89.80 ± 23.95

36.05 ± 29.01

7.93 ± 11.36

Female, Alive (n = 1,524)

88.18 ± 21.99

35.01 ± 27.11

7.49 ± 10.81

Significance

p = 0.230

p = 0.990

p = 0.518

* Measured across a five minute interval for each sample
Values for heart rate and PNN50 were significantly different (p < 0.01) across gender and
mortality classes, with the exception of female mortality, for which heart rate and PNN50 were
not significantly different between female patients that survived past 90 days and those that
expired within 90 days. Values for SDNN were significantly different (p = 0.009) only between
male and female patients, with no statistically significant difference between other classes. A
slight, though significant (p < 0.01), increase is noted in all values in female patients. Consistent
with previous research, patients that expire within 90 days have a somewhat higher heart rate
compared to other patients, however HRV values are somewhat higher as well, contrary to
previous research (Table 1).
A total of 31 patients within the full waveform database directory fulfilled the
requirements for having an adequate range of recordings within 30 days of death. Of these
patients, 18 failed the same requirements after processing, losing some recording data due to
noisy ECG signals. From the 13 remaining patients, 4 were selected for deeper analysis based on
both total range of recording days within the 30 day mark and proximity of latest recording to
official date of death. The resulting graphs generated from these patients are shown below.
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Figure 1 Average heart rate of four patients (A-D) from recordings taken within 30 days of
eventual patient death.
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Figure 2. Average standard deviation of NN intervals (SDNN) of four patients (A-D) taken
within 30 days of eventual patient death.
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Figure 3. Average percentage of subsequent NN intervals that differ by more than 50 ms
(PNN50) of four patients (A-D) taken within 30 days of eventual patient death.
Across all four patients, two showed a higher heart rate between their final and
penultimate recordings, one showed a lower heart rate, and one showed a similar heart rate
(Figure 1). Three showed a lower SDNN and PNN50 value between their final and penultimate
recordings, however patient B’s final value for both HRV measures was still higher than their
first recorded value. Patient A showed a higher SDNN and PNN50, though their final value for
SDNN was similar to earlier values in the examined timeframe (Figure 2-3). Of all patients,
patient C showed the most drastic and consistent change in HRV values over time, with SDNN
decreasing by 60 ms and PNN50 decreasing by 30 percentage points.
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Figure 4. Logistic regression modeling results. Class 0 represents the living class, while class 1
represents the class of patients that passed away within 90 days of recording start.
Logistic regression analysis showed little to no success in differentiating data between
patients within 90 days of death and other patients. Due to the large and almost entirely
overlapping range of the data between both groups, the created model was heavily biased
towards classification as the class alive after 90 days, as the larger portion of the dataset. Of
validation samples from patients that passed away within 90 days, the model was unable to
assign any as the correct class, assigning all samples to the living class (Figure 4).

Discussion
While results were somewhat inconclusive due to high variance in measured HRV
statistics, the process of utilizing MIMIC-III data to investigate patient mortality in relation to
such statistics has provided many insights into how HRV data fits into a patient’s health record
and what considerations should be taken into account in future research and structuring of
publicly available datasets. Heart rate and PNN50 were found to be statistically significant
between patients that passed away within 90 days and those that lived after 90 days, however a
closer investigation into patient gender and mortality combined showed that this wasn’t the case
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for examining female patient mortality. This may be due to the lower number of female patients
in the sample set, with 2,366 male patient admissions and 1,893 female patient admissions. More
data on female patients could clarify this difference, if unable to bring it more in line with other
results. Nonetheless, SDNN was negligibly different between classes in all cases except in
comparing both genders. For both HRV measures, mean values were unexpectedly higher when
examining patients with 90 day mortality vs patients who lived past 90 days. This may be due to
the relatively short 90 day timeframe in comparison to previous studies, which examined
mortality on the scale of years more so than months. It may be that HRV values increase closer
to the date of death, however more analysis is needed. Ultimately, more data and a greater focus
on patient trends, as opposed to different hospital visits being treated independently, may be
beneficial in future work.
This study was subject to a number of limitations. A notable constraint on the
computational side of things was the amount of data available in the MIMIC-III waveform
database, and future work should take into account the machine requirements for storing and
processing multiple terabytes of data. While early statistical analysis on patients with greater
amounts of data showed a similar difference between patients that passed away within 90 days of
recording and living patients, more data would better illustrate each patient’s health and better
protect against possibly poor reliability of data, as it is currently gathered solely from a single
five minute window of ECG data.
Context of recording is equally important to having high quality HRV data. HRV
statistics are naturally tied to activity and other factors. As HRV tends to increase while an
individual is asleep, a five minute recording of such an individual can reflect a higher HRV than
would be expected from a typical five minute recording, taken at rest as is standard. Monitoring
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of patient activity and/or segmentation of ECG recordings according to patient status could
counteract some of these uncertainties. This area in particular may contribute to the success of
previous studies in predicting mortality with HRV statistics, as hands-on research lends itself
naturally to strict control over sample context.
Another limitation of this study and/or the dataset involves the organization of data
surrounding patient diagnoses. The MIMIC-III dataset provides two areas in which diagnosis
information is present; a diagnosis table provides all official ICD-9 (International Classification
of Diseases, version 9) codes of patient diagnoses, and the admissions table provides one or more
plain-text diagnoses that are related to their hospital stay. When examining elements that have an
impact on HRV statistics, the context of what ailments have contributed most to a hospital stay
can be very beneficial. The ability to derive these diagnoses from the dataset would give further
insight into how patient health may be affected by their HRV and vice versa. For future work,
classification by ICD-9 code within this admissions dataset or usage of a text processing tool to
derive these ICD-9 codes from plain text may allow for groups of patients to be better delineated
along the lines of which particular pathologies are the most concerning. A comprehensive list of
all ICD-9 diagnoses, which is stored in the diagnosis table, can clutter such data with less
concerning data when it comes to evaluating HRV impacting ailments, though still important
contextual information.
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